How Long Does Kliovance Take To Work? Complete Efficacy Timeline

Onset of Action, Absorption Rate, Longevity, Peak Concentration & Duration Explained

Key Takeaways: Kliovance Timeline

  • Absorption: Norethisterone peaks 1‑2 hours after taking; estradiol peaks 3‑7 hours.
  • Onset of symptom relief: Most women notice improvement in hot flushes within 2‑4 weeks.
  • Peak effect: Maximum relief typically occurs after 8‑12 weeks of continuous use.
  • Duration in body: Estradiol half‑life ~12‑14 hours; norethisterone half‑life ~5‑9 hours. Steady state reached in 3‑5 days.
  • Complete elimination: After stopping, the drugs are cleared from the body within 3‑5 days.
  • Long‑term outcomes: Bone protection requires at least 6‑12 months of consistent treatment.

If you're starting Kliovance, you likely want to know how soon you'll feel better and how long the effects last. This guide breaks down the exact pharmacokinetic timeline—from absorption and onset to peak concentration and elimination—so you know what to expect week by week and how the medicine behaves in your body.

When to Seek Urgent Help

If you experience sudden chest pain, breathlessness, severe headache, or signs of a blood clot (swollen painful leg), stop Kliovance and seek immediate medical attention. These are not related to the normal timeline but require prompt assessment.

Efficacy Timeline: When to Expect Results from Kliovance

The timeline for Kliovance’s effects depends on whether you are treating acute menopausal symptoms or aiming for long‑term bone protection. The table below summarises the key milestones.

TimepointExpected Outcome
1‑3 hoursAbsorption complete; hormones reach systemic circulation.
2‑4 weeksReduction in hot flushes, night sweats, and sleep disturbances begins.
8‑12 weeksMaximal symptom relief achieved; mood and vaginal dryness often significantly improved.
6‑12 monthsBone mineral density (BMD) starts to increase; fracture risk reduction becomes measurable.
Beyond 12 monthsSustained benefits with continued treatment; annual review to reassess risks and benefits.

It is important to note that individual responses vary. Some women feel improvement within the first two weeks, while others may need up to three months for full relief. Bone protection requires long‑term adherence—stopping therapy reverses the BMD gains.

Absorption Rate: How Fast Kliovance Enters the Body

Kliovance tablets are taken orally. After swallowing, both active components are rapidly absorbed from the gastrointestinal tract.

  • Norethisterone acetate is quickly deacetylated to norethisterone. Peak plasma concentrations occur 1‑2 hours after dosing.
  • Estradiol undergoes first‑pass metabolism in the gut and liver, resulting in lower systemic bioavailability (~5%). Nevertheless, peak plasma levels are reached between 3 and 7 hours post‑dose.
  • Food does not significantly alter absorption; you may take it with or without meals.

📊 Absorption insight: The rapid absorption of norethisterone ensures that progestogen protection begins almost immediately, which is why breakthrough bleeding is rare when taken consistently.

Peak Concentration & Onset of Symptom Relief

Peak plasma levels: After reaching peak levels (Cmax), the hormones distribute to target tissues. Estradiol binds to oestrogen receptors in the hypothalamus, bone, and urogenital tract, while norethisterone acts on progesterone receptors in the endometrium.

Onset of clinical action: Although circulating levels peak within hours, the symptomatic improvement takes days to weeks because it involves gene transcription and cellular changes. In clinical studies, 50‑70% of women report noticeable relief from hot flushes by week 4. The full therapeutic effect typically requires 8‑12 weeks of consistent daily use.

For endometrial protection, the progestogen component is effective from the first dose, provided it is taken daily without interruption.

Duration in Body: How Long Kliovance’s Effects Last

Once you are taking Kliovance daily, the body reaches steady state after approximately 3‑5 days. At steady state, the concentration remains fairly constant between doses, providing continuous symptom relief and endometrial protection.

The duration of action is essentially the length of time between doses. Because the half‑life of estradiol is 12‑14 hours and norethisterone is 5‑9 hours, taking one tablet every 24 hours maintains effective levels. Missing a dose by more than 12 hours can lead to a drop in hormone levels, which may trigger spotting or a return of symptoms.

Long‑term effects: For bone density, the beneficial effects accumulate over months. Discontinuation leads to gradual loss of BMD at a rate similar to untreated postmenopausal women.

How Long It Takes to Enter the Body (Absorption Phase)

The term “enter the body” refers to the time from ingestion until the active ingredients appear in the bloodstream in measurable amounts. For Kliovance:

  • Norethisterone is detectable in plasma within 15‑30 minutes; it reaches peak concentration at 1‑2 hours.
  • Estradiol begins to enter the circulation within 30‑60 minutes, with peak levels at 3‑7 hours.

Therefore, within the first hour after taking a tablet, both hormones are actively entering the body and beginning to exert their effects.

How Long It Takes to Leave the Body (Elimination)

Once you stop taking Kliovance, the elimination half‑life determines how quickly the hormones are cleared.

  • Estradiol: Half‑life of 12‑14 hours. It takes about 2.5‑3 days (5‑6 half‑lives) for complete elimination from the body.
  • Norethisterone: Half‑life of 5‑9 hours. It is typically cleared within 1.5‑2 days.

Thus, after the last tablet, both hormones are essentially undetectable in the body within 3‑5 days. This explains why menopausal symptoms may return quickly after stopping treatment.

⚠️ Clinical reminder: If you are undergoing surgery, your doctor may ask you to stop Kliovance 4‑6 weeks beforehand—not because the drug remains in your body, but to reduce the risk of blood clots associated with hormonal effects that persist beyond mere drug presence.

Efficacy Rate: How Well Does Kliovance Work?

Kliovance is highly effective when used as prescribed. In randomised controlled trials:

  • Vasomotor symptoms: 80‑90% reduction in hot flush frequency and severity after 12 weeks of continuous use.
  • Urogenital atrophy: Significant improvement in vaginal dryness, dyspareunia, and urinary urgency within 2‑3 months.
  • Bone protection: Increases lumbar spine BMD by 3‑5% over 2 years, reducing fracture risk by approximately 30‑40% compared to placebo.
  • Endometrial safety: The addition of norethisterone reduces the risk of endometrial hyperplasia to less than 1% over long‑term use, comparable to non‑users.

Patient adherence is critical: the high efficacy rates are achieved only when the medicine is taken daily without interruption. Intermittent use or missed doses significantly reduce effectiveness and may cause irregular bleeding.

Kliovance Timeline FAQs

Most women notice a reduction in hot flushes and night sweats within 2‑4 weeks. Maximum benefit is typically achieved by 8‑12 weeks of daily use.

Estradiol clears in about 3 days; norethisterone clears within 1‑2 days. Complete elimination occurs within 3‑5 days after the last dose.

No. Taking more than the prescribed dose does not speed up results and increases the risk of side effects like breast tenderness, nausea, and thrombosis. Always follow the one‑tablet‑daily regimen.

Bone mineral density improvements begin after 6‑12 months of continuous use. To maintain fracture protection, long‑term adherence (often several years) is required.

Vaginal dryness often improves within 2‑4 weeks, but some women may take up to 3 months to experience full restoration of vaginal moisture and comfort.

Ready to Start Kliovance with Expert Guidance?

Understanding the timeline helps set realistic expectations, but every woman’s response is unique. A UK‑registered doctor can review your medical history, prescribe the right HRT, and monitor your progress.

Secure Prescription & Next-Day Delivery

GPhC‑registered pharmacy | Discreet packaging | Ongoing clinical support

Start Menopause Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 27 March 2026

Next Review: 27 September 2026

Published on: 27 March 2026

Last Updated: 27 March 2026